Teng I-Chia, Sun Cheuk-Kwan, Ho Chun-Ning, Wang Li-Kai, Lin Yao-Tsung, Chang Ying-Jen, Chen Jen-Yin, Chu Chin-Chen, Hsing Chung-Hsi, Hung Kuo-Chuan
Department of Anaesthesiology, Chi Mei Medical Centre, Tainan, Taiwan.
Department of Emergency Medicine, E-Da Hospital, Kaohsiung city, Taiwan; College of Medicine, I-Shou University, Kaohsiung city, Taiwan.
Anaesth Crit Care Pain Med. 2022 Oct;41(5):101119. doi: 10.1016/j.accpm.2022.101119. Epub 2022 Jun 28.
To investigate the efficacy of combined epidural anaesthesia/analgesia (EAA) against postoperative delirium/cognitive dysfunction (POD/POCD) in adults after major non-cardiac surgery under general anaesthesia (GA).
The databases of PubMed, Google Scholar, Embase and Cochrane Central Register were searched from inception to November 2021 for available randomised controlled trials (RCTs) that assessed the impact of EAA on risk of POD/POCD. The primary outcome was risk of POD/POCD, while the secondary outcomes comprised postoperative pain score, length of hospital stay (LOS), risk of complications, and postoperative nausea/vomiting (PONV).
Meta-analysis of eight studies with a total of 2376 patients (EAA group: 1189 patients; non-EAA group: 1187 patients) revealed no difference in risk of POD/POCD between the EAA and the non-EAA groups [Risk ratio (RR): 0.68; 95% CI: 0.41 to 1.13, p = 0.14, I = 73%], but the certainty of evidence was very low. Nevertheless, the EAA group had lower pain score at postoperative 24 h [mean difference (MD): -1.49, 95% CI: -2.38 to -0.61; I = 98%; five RCTs; n = 476] and risk of PONV (RR = 0.73, 95% CI: 0.57 to 0.93, p = 0.01, I = 0%; three RCTs, 1876 patients) than those in the non-EAA group. Our results showed no significant impact of EAA on the pain score at postoperative 36-72 h, LOS, and risk of complications.
This meta-analysis demonstrated that EAA had no significant impact on the incidence of POD/POCD in patients following non-cardiac surgery.
探讨全身麻醉(GA)下接受非心脏大手术的成人患者中,联合硬膜外麻醉/镇痛(EAA)预防术后谵妄/认知功能障碍(POD/POCD)的疗效。
检索PubMed、谷歌学术、Embase和Cochrane中心对照试验注册库,纳入自建库起至2021年11月期间评估EAA对POD/POCD风险影响的随机对照试验(RCT)。主要结局为POD/POCD风险,次要结局包括术后疼痛评分、住院时间(LOS)、并发症风险及术后恶心/呕吐(PONV)。
对8项研究共2376例患者(EAA组:1189例患者;非EAA组:1187例患者)进行的荟萃分析显示,EAA组与非EAA组在POD/POCD风险方面无差异[风险比(RR):0.68;95%置信区间(CI):0.41至1.13,p = 0.14,I² = 73%],但证据确定性非常低。然而,EAA组术后24小时疼痛评分更低[平均差(MD):-1.49,95%CI:-2.38至-0.61;I² = 98%;5项RCT;n = 476],PONV风险也低于非EAA组(RR = 0.73,95%CI:0.57至0.93,p = 0.01,I² = 0%;3项RCT,1876例患者)。我们的结果表明,EAA对术后36 - 72小时疼痛评分、LOS及并发症风险无显著影响。
该荟萃分析表明,EAA对非心脏手术后患者POD/POCD的发生率无显著影响。